v3.25.1
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF SHARE OPTION ACTIVITY

The following table sets forth the share option activities for the fiscal years ended March 31, 2023, 2024 and the nine months ended December 31, 2024:

  

   Number of shares   Weighted-average exercise price   Weighted average remaining contractual term   Aggregate
intrinsic
value		   Weighted average fair value of options 
       US$   YEARS   US$’000   US$ 
                     
Outstanding as of March 31, 2022   18,513,407    0.75    6.01    2,405.17    1.23 
                          
Granted   10,429,567    -*    -    -    0.13 
Forfeited   (1,353,071)   0.81    -    -    0.33 
Exercised   (933,285)   0.01    -    -    0.34 
                          
Outstanding as of March 31, 2023   26,656,618    0.48    6.83    9,585.96    0.88 
                          
Granted   22,064,611    -*    -    -    0.04 
Forfeited   (4,522,500)   0.86    -    -    1.81 
Exercised   (6,880,590)   -*    -    -    0.11 
                          
Outstanding as of March 31, 2024   37,318,139    0.24    7.67    8,898.37    0.44 
                          
Granted   10,544,400    -*    -    -    0.01 
Forfeited   (2,078,339)   0.90    -    -    1.68 
Exercised   (14,181,600)   -*    -    -    0.04 
                          
Outstanding as of December 31, 2024   31,602,600    0.21    3.60    14,336.67    0.38 
Vested and expected to vest as of December 31, 2024   31,602,600    0.21    3.60    14,336.67    0.38 
Exercisable as of December 31, 2024   31,602,600    0.21    3.60    14,336.67    0.38 

 

*Less than 0.01
SCHEDULE OF RESTRICTED SHARE ACTIVITY

The following table sets forth the restricted share activity for the fiscal years ended March 31, 2023, 2024 and the nine months ended December 31, 2024:

 

   Number of
shares		   Weighted average grant date fair value 
       US$ 
         
Unvested as of March 31, 2022   -    - 
           
Granted   2,844,235    0.13 
Vested   (2,844,235)   0.13 
           
Unvested as of March 31, 2023   -    - 
           
Granted   2,871,270    0.05 
Vested   (2,871,270)   0.05 
           
Unvested as of March 31, 2024 and December 31, 2024   -    - 
Granted   -    - 
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSES BY FUNCTION

The following table sets forth the amounts of share-based compensation expense included in each of the relevant financial statement line items:

 

   2023   2024   2024 
  

For the fiscal year ended

March 31,

   For the nine months ended December 31, 
   2023   2024   2024 
   RMB   RMB   RMB 
             
General and administrative expenses   44,088    72,942    84,663 
Research and development expenses   1,709    1,420    128 
Sales and marketing expenses   1,516    1,444    136 
Total   47,313    75,806    84,927